You searched for "Head and Neck"

173 results found

What is the prognostic value of lymph node yield and density in head and neck cancer?

Neck dissection in addition to surgery of the primary site is commonly recommended in head and neck cancer treatment. However, there has been no consensus on the number of nodes that need to be removed to constitute a sufficient neck...

Risk of second primary cancer among patients with head and neck cancers

Patients with head and neck squamous cell carcinoma (HNSCC) have an elevated risk of developing a second primary malignant neoplasm (SPMN). These are of increasing concern because the number of survivors of HNSCC has been growing owing to early detection...

Prophylactic gastrostomy tubes in advance of chemoradiotherapy for advanced head and neck malignancies – are they worthwhile?

It is well recognised that radical chemoradiotherapy (CRT) for head and neck cancers can significantly affect swallowing, especially if radiotherapy is delivered to the hypopharynx and/or both sides of the neck. As such, prophylactic gastrostomy tubes are often advocated in...

A safe management pathway for low-risk head and neck cancer suspected referrals

Head and neck cancer is the eighth most common malignancy and numbers are increasing. This has led to increasing number of suspected cancer referrals which, with imposition of the 28-day Faster Diagnosis Standard implemented in 2020, has further burdened the...

Treatment regret in head and neck cancer – trading function for survival

Treatment for H&N cancer can be extremely tough for patients. How do we explain the likely impact as they try to make decisions? And what happens when they regret their choice? Treatment regret is a form of decision regret, involving...

Exploring the role of oral microbiota in head and neck squamous cell carcinoma

Oral microbiota, especially Fusobacterium nucleatum, may improve survival and guide personalised treatment in head and neck squamous cell carcinoma. Head and neck squamous cell carcinoma (HNSCC) is a devastating disease with a low five-year survival rate that has shown little...

Which patients are suitable for surgery in recurrent head and neck cancer?

Currently, radiotherapy and chemotherapy is the most common modality used in the management of primary head and neck squamous cell carcinomas (HNSCC). Unfortunately, around 50% of patients experience disease recurrence (rHNSCC). Surgery is therefore often used as a salvage treatment....

Progress of head and neck surgery in China over the last 20 years

Although China was late to establish head and neck surgery in comparison to other areas of oncological surgery, with the persistent hard work of head and neck surgeons nationally, it has progressed significantly during the last two decades. Yueying Ma...

Changing perceptions in head and neck cancer management caused by quality of life issues

Sir Felix Semon was an outstanding clinician and exceptional laryngologist. The money raised by donations from his colleagues on his retirement in 1909 was used to establish the London University’s Semon Lecture. Semon’s Obituary in the BMJ, reads: “In Semon's...

Robotic head and neck surgery: current state of the art and future innovations

Technology and innovation has provided modern head and neck surgeons with successive generations of robotic surgical systems, fibre-optic lasers, and novel tools which have ushered in a new era of minimally invasive surgery for tumours of the pharynx and larynx....

Ear, Nose, and Throat Diseases With Head and Neck Surgery – Fourth Edition

In the fourth edition of this internationally recognised text, Professor Hans Behrbohm and his co-authors have taken over authorship from Professors Walter Becker, Hans Heinz Naumann and Carl Rudolph Pfaltz. This latest edition from Thieme has had existing chapters updated...